2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.
作者信息
Richard Patrick O, Violette Philippe D, Bhindi Bimal, Breau Rodney H, Gratton Matthieu, Jewett Michael A S, Kapoor Anil, Pouliot Frederic, Leveridge Michael, So Alan I, Whelan Tom F, Rendon Ricardo A, Tanguay Simon, Finelli Antonio
机构信息
Division of Urology, Department of Surgery, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada.
Division of Urology, Woodstock General Hospital, Woodstock, ON , Canada.
出版信息
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
Abstract
摘要
相似文献
1
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
2
Gender disparity within the Canadian Urological Association A comparison with the Quebec Urological Association.
Can Urol Assoc J. 2024 Jan;18(1):E1-E6. doi: 10.5489/cuaj.8436.
3
Peer-reviewed publications by CUA members: then and now.
Can Urol Assoc J. 2010 Dec;4(6):385-90. doi: 10.5489/cuaj.950.
5
Canadian guidelines for the management of benign prostatic hyperplasia.
Can J Urol. 2005 Jun;12(3):2677-83.
6
UPDATE - 2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) castration-resistant prostate cancer (CRPC) guideline: What has changed since 2019?
Can Urol Assoc J. 2021 Feb;15(2):11-12. doi: 10.5489/cuaj.7160.
7
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074.
8
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136.
9
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2022 Nov;16(11):E506-E515. doi: 10.5489/cuaj.8161.
10
Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: Turning urine into gold.
Can Urol Assoc J. 2019 Dec;13(12):406-411. doi: 10.5489/cuaj.5809. Epub 2019 Feb 7.
引用本文的文献
1
Assessing the methodologic heterogeneity of Canadian Urological Association guidelines Adoption of the GRADE approach (2018-2023).
Can Urol Assoc J. 2025 Jun;19(6):173-180. doi: 10.5489/cuaj.8926.
2
Rapid recommendations: Updates from 2023 guidelines: part 2.
Can Fam Physician. 2024 Oct;70(10):632-633. doi: 10.46747/cfp.7010632.
3
Updated cystic renal lesions guideline: A springboard for shared decision-making.
Can Urol Assoc J. 2023 Jun;17(6):175. doi: 10.5489/cuaj.8388.
本文引用的文献
1
Evolution of Bosniak IIF Renal Cysts and Impact of the 2019 Bosniak Classification.
J Urol. 2023 Apr;209(4):694-700. doi: 10.1097/JU.0000000000003112. Epub 2022 Dec 27.
2
Active surveillance versus initial surgery in the long-term management of Bosniak IIF-IV cystic renal masses.
Sci Rep. 2022 Jun 17;12(1):10184. doi: 10.1038/s41598-022-14056-6.
3
Canadian Urological Association guideline: Management of small renal masses - Full-text.
Can Urol Assoc J. 2022 Feb;16(2):E61-E75. doi: 10.5489/cuaj.7763.
4
Assessment of the workload and financial burden of Bosniak IIF renal cyst surveillance in a tertiary referral hospital.
Ir J Med Sci. 2022 Dec;191(6):2771-2775. doi: 10.1007/s11845-022-02919-w. Epub 2022 Jan 17.
5
Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use.
Radiographics. 2022 Jan-Feb;42(1):E33. doi: 10.1148/rg.219016.
6
Interrater Agreement of Bosniak Classification Version 2019 and Version 2005 for Cystic Renal Masses at CT and MRI.
Radiology. 2022 Feb;302(2):357-366. doi: 10.1148/radiol.2021210853. Epub 2021 Nov 2.
7
Role of contrast-enhanced ultrasound in assessing indeterminate renal lesions and Bosniak ≥2F complex renal cysts found incidentally on CT or MRI.
Br J Radiol. 2021 Nov 1;94(1127):20210707. doi: 10.1259/bjr.20210707. Epub 2021 Aug 31.
8
Using Contrast-Enhanced Ultrasound in Addition to Cross-Sectional Imaging for Indeterminate Renal Cysts May Lead to Overclassification in Bosniak III Category: A Case-Control Study.
Eur Surg Res. 2022;63(1):19-24. doi: 10.1159/000517405. Epub 2021 Jul 21.
9
Inter-observer and intra-observer agreement of Bosniak classification of cystic renal masses: Comparison between original version to version 2019 and effect of an online support calculator.
Can Urol Assoc J. 2021 Dec;15(12):420-422. doi: 10.5489/cuaj.7369.
10
Evaluation of class II cystic renal masses proposed in Bosniak classification version 2019: a systematic review of supporting evidence.
Abdom Radiol (NY). 2021 Oct;46(10):4888-4897. doi: 10.1007/s00261-021-03180-y. Epub 2021 Jun 21.
Zotero 插件